Integration of novel materials and advanced genomic technologies into new vaccine design

Wenzhen Liao, Tian Tian Zhang, Liqian Gao, Su Seong Lee, Jie Xu, Han Zhang, Zhaogang Yang, Zhaoyu Liu, Wen Li

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Designing new vaccines is one of the most challenging tasks for public health to prevent both infectious and chronic diseases. Even though many research scientists have spent great efforts in improving the specificity, sensitivity and safety of current available vaccines, there are still much space on how to effectively combine different biomaterials and technologies to design universal or personalized vaccines. Traditionally, vaccines were made based on empirical approaches designed to mimic immunity induced by natural infection. Either live attenuated or killed whole microorganisms were used as vaccines. With the development of biomaterial science, DNA/RNA, recombinant vector, adjuvant and nanoparticles greatly expand the category of vaccines. More importantly, with the tremendous advances of new technologies including genomics, proteomics and immunomics, the paradigm of vaccine design has shifted from microbiological to sequence-based approaches. This ever-growing large amount of genomic data and new genomic approaches such as comparative genomics, reverse vaccinology and pan-genomics, will play critical roles in novel vaccine design and enable development of more effective vaccines to cure and control both chronic and infectious diseases. In this review, we summarize current various vaccine materials, advanced technologies and combinational strategies to integrate biomaterials and advanced technologies for vaccine design, which we hope will provide some very useful guidelines and perspectives for the vaccine design.

Original languageEnglish (US)
Pages (from-to)2286-2301
Number of pages16
JournalCurrent Topics in Medicinal Chemistry
Volume17
Issue number20
DOIs
StatePublished - Aug 1 2017

Fingerprint

Vaccines
Technology
Biocompatible Materials
Genomics
Communicable Diseases
Chronic Disease
Recombinant DNA
Innate Immunity
Proteomics
Nanoparticles
Public Health
Guidelines
Safety
Sensitivity and Specificity
Infection
Research

All Science Journal Classification (ASJC) codes

  • Drug Discovery

Cite this

Liao, Wenzhen ; Zhang, Tian Tian ; Gao, Liqian ; Lee, Su Seong ; Xu, Jie ; Zhang, Han ; Yang, Zhaogang ; Liu, Zhaoyu ; Li, Wen. / Integration of novel materials and advanced genomic technologies into new vaccine design. In: Current Topics in Medicinal Chemistry. 2017 ; Vol. 17, No. 20. pp. 2286-2301.
@article{e06fde3f4366434d9fde29c994092e40,
title = "Integration of novel materials and advanced genomic technologies into new vaccine design",
abstract = "Designing new vaccines is one of the most challenging tasks for public health to prevent both infectious and chronic diseases. Even though many research scientists have spent great efforts in improving the specificity, sensitivity and safety of current available vaccines, there are still much space on how to effectively combine different biomaterials and technologies to design universal or personalized vaccines. Traditionally, vaccines were made based on empirical approaches designed to mimic immunity induced by natural infection. Either live attenuated or killed whole microorganisms were used as vaccines. With the development of biomaterial science, DNA/RNA, recombinant vector, adjuvant and nanoparticles greatly expand the category of vaccines. More importantly, with the tremendous advances of new technologies including genomics, proteomics and immunomics, the paradigm of vaccine design has shifted from microbiological to sequence-based approaches. This ever-growing large amount of genomic data and new genomic approaches such as comparative genomics, reverse vaccinology and pan-genomics, will play critical roles in novel vaccine design and enable development of more effective vaccines to cure and control both chronic and infectious diseases. In this review, we summarize current various vaccine materials, advanced technologies and combinational strategies to integrate biomaterials and advanced technologies for vaccine design, which we hope will provide some very useful guidelines and perspectives for the vaccine design.",
author = "Wenzhen Liao and Zhang, {Tian Tian} and Liqian Gao and Lee, {Su Seong} and Jie Xu and Han Zhang and Zhaogang Yang and Zhaoyu Liu and Wen Li",
year = "2017",
month = "8",
day = "1",
doi = "10.2174/1568026617666170224122117",
language = "English (US)",
volume = "17",
pages = "2286--2301",
journal = "Current Topics in Medicinal Chemistry",
issn = "1568-0266",
publisher = "Bentham Science Publishers B.V.",
number = "20",

}

Liao, W, Zhang, TT, Gao, L, Lee, SS, Xu, J, Zhang, H, Yang, Z, Liu, Z & Li, W 2017, 'Integration of novel materials and advanced genomic technologies into new vaccine design', Current Topics in Medicinal Chemistry, vol. 17, no. 20, pp. 2286-2301. https://doi.org/10.2174/1568026617666170224122117

Integration of novel materials and advanced genomic technologies into new vaccine design. / Liao, Wenzhen; Zhang, Tian Tian; Gao, Liqian; Lee, Su Seong; Xu, Jie; Zhang, Han; Yang, Zhaogang; Liu, Zhaoyu; Li, Wen.

In: Current Topics in Medicinal Chemistry, Vol. 17, No. 20, 01.08.2017, p. 2286-2301.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Integration of novel materials and advanced genomic technologies into new vaccine design

AU - Liao, Wenzhen

AU - Zhang, Tian Tian

AU - Gao, Liqian

AU - Lee, Su Seong

AU - Xu, Jie

AU - Zhang, Han

AU - Yang, Zhaogang

AU - Liu, Zhaoyu

AU - Li, Wen

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Designing new vaccines is one of the most challenging tasks for public health to prevent both infectious and chronic diseases. Even though many research scientists have spent great efforts in improving the specificity, sensitivity and safety of current available vaccines, there are still much space on how to effectively combine different biomaterials and technologies to design universal or personalized vaccines. Traditionally, vaccines were made based on empirical approaches designed to mimic immunity induced by natural infection. Either live attenuated or killed whole microorganisms were used as vaccines. With the development of biomaterial science, DNA/RNA, recombinant vector, adjuvant and nanoparticles greatly expand the category of vaccines. More importantly, with the tremendous advances of new technologies including genomics, proteomics and immunomics, the paradigm of vaccine design has shifted from microbiological to sequence-based approaches. This ever-growing large amount of genomic data and new genomic approaches such as comparative genomics, reverse vaccinology and pan-genomics, will play critical roles in novel vaccine design and enable development of more effective vaccines to cure and control both chronic and infectious diseases. In this review, we summarize current various vaccine materials, advanced technologies and combinational strategies to integrate biomaterials and advanced technologies for vaccine design, which we hope will provide some very useful guidelines and perspectives for the vaccine design.

AB - Designing new vaccines is one of the most challenging tasks for public health to prevent both infectious and chronic diseases. Even though many research scientists have spent great efforts in improving the specificity, sensitivity and safety of current available vaccines, there are still much space on how to effectively combine different biomaterials and technologies to design universal or personalized vaccines. Traditionally, vaccines were made based on empirical approaches designed to mimic immunity induced by natural infection. Either live attenuated or killed whole microorganisms were used as vaccines. With the development of biomaterial science, DNA/RNA, recombinant vector, adjuvant and nanoparticles greatly expand the category of vaccines. More importantly, with the tremendous advances of new technologies including genomics, proteomics and immunomics, the paradigm of vaccine design has shifted from microbiological to sequence-based approaches. This ever-growing large amount of genomic data and new genomic approaches such as comparative genomics, reverse vaccinology and pan-genomics, will play critical roles in novel vaccine design and enable development of more effective vaccines to cure and control both chronic and infectious diseases. In this review, we summarize current various vaccine materials, advanced technologies and combinational strategies to integrate biomaterials and advanced technologies for vaccine design, which we hope will provide some very useful guidelines and perspectives for the vaccine design.

UR - http://www.scopus.com/inward/record.url?scp=85027325680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027325680&partnerID=8YFLogxK

U2 - 10.2174/1568026617666170224122117

DO - 10.2174/1568026617666170224122117

M3 - Review article

C2 - 28240182

AN - SCOPUS:85027325680

VL - 17

SP - 2286

EP - 2301

JO - Current Topics in Medicinal Chemistry

JF - Current Topics in Medicinal Chemistry

SN - 1568-0266

IS - 20

ER -